Autres langues Transgene

Actions

TNG

FR0005175080

Marché Fermé - Euronext Paris Autres places de cotation 17:18:10 07/06/2024			Varia. 5j.	Varia. 1 janv.
1,302 ^EUR	0,00 %		+5,00 %	-4,96 %

03/06	Transgene : premier patient de l'étude de phase II	CF
03/06	Transgene: démarrage de l'étude évaluant le TG4050	AO

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Transgene : premier patient de l'étude de phase II	03/06
Borsa di Italia: Facci sognare, Christine	03/06
Bolsa de Madrid: Haznos soñar, Christine	03/06
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer	03/06
Transgene : 2024 First Quarter	16/05
Transgene’s Combined General Meeting of May 15, 2024	15/05
Transgene provides business and financial update for Q1 2024	14/05
Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024	24/04
Availability of Transgene's 2023 Universal Registration Document	11/04
Actualización de las fuertes variaciones del día: HSBC, Barry Callebaut y WPP en verde	10/04
Transgene : présente les résultats d'un vaccin à l'AACR	10/04
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024	09/04
Transgene CFO Steps Down; Successor Assumes Office	28/03
Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025	27/03
Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources Officer	27/03
Transgene SA Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Transgene SA Announces Chief Financial Officer Changes	27/03
Transgene SA Promotes Christelle Schwoerer to Chief Human Resources Officer, Effective from April 1, 2024, and She Also Joins the Executive Committee	27/03
Transgene Announces Upcoming Investor Meetings	18/03
Transgene Announces Upcoming Investor Meetings	18/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Transgene

Actions

TNG

FR0005175080

Autres langues

Filtres